Retrospective analysis and clinical performance of BD MAX enteric pathogen testing with a focus on reliable identification of vibrio species in stool samples
- 25 January 2025
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 111 (4) , 116715
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Impact of gastrointestinal polymerase chain reaction panels on antibiotic utilization in hospitalized adult patientsAntimicrobial Stewardship & Healthcare Epidemiology, 2023
- Climate warming and increasing Vibrio vulnificus infections in North AmericaScientific Reports, 2023
- Future scenarios of risk of Vibrio infections in a warming planet: a global mapping studyThe Lancet Planetary Health, 2021
- Evidence of False Positivity forVibrioSpecies Tested by Gastrointestinal Multiplex PCR Panels, Minnesota, 2016–2018Open Forum Infectious Diseases, 2021
- Clinical Impact of a Multiplex Gastrointestinal Polymerase Chain Reaction Panel in Patients With Acute GastroenteritisClinical Infectious Diseases, 2018
- Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control studyThe Lancet, 2016
- Comparison of the BD MAX® Enteric Bacterial Panel assay with conventional diagnostic procedures in diarrheal stool samplesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2015
- Case–control comparison of bacterial and protozoan microorganisms associated with gastroenteritis: application of molecular detectionClinical Microbiology and Infection, 2015
- Diarrhea in the Immunocompromised PatientGastroenterology Clinics of North America, 2012
- VIRAL CAUSES OF DIARRHEAGastroenterology Clinics of North America, 2001